NYSE · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $8.5B | $29.9M | $288.8M | 15.1% | 63,512,000 |
| FY2021 | $9.8B | $221.6M | $83.2M | 15.5% | 75,486,000 |
| FY2022 | $10.0B | $22.4M | $166.9M | 18.3% | 76,217,000 |
| FY2023 | $10.3B | −$41.3M | $549.8M | 20.6% | 75,785,000 |
| FY2024 | $10.7B | −$362.7M | −$49.4M | 20.7% | 76,741,000 |
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Companies filing in the same SEC industry group.
Where dealer gamma sat in ACH’s option chain after the close on 2026-09-01, aggregated from the full chain. This is a once-a-day snapshot, not a live read — 46 contracts.
Computed from the listed option chain by my own aggregation, once, after the close — it describes where positioning sat that evening and does not update through the next session. The version that rebuilds per strike while the market is open is the intraday gamma product. Not investment advice.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
| FY2025 |
| $2.8B |
| −$1.1B |
| −$292.7M |
| — |
| 76,897,000 |
